Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| FE | Somerhalder John W Ii | Director | 01.10.2026 | Zuteilung | 43,10 | 986 | 42.497 | Form 4 |
| FELE | Sengstack Gregg C | Director | 01.10.2026 | Steuer-Abgabe | 96,47 | 145 | 13.988 | Form 4 |
| FELE | Sengstack Gregg C | Director | 01.10.2026 | Zuteilung | 96,47 | 366 | 35.308 | Form 4 |
| FENC | Cioffi Christiana Marie | Chief Strategy Officer | 30.09.2026 | Zuteilung | — | 156 | — | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 30.09.2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Evans Terry L | Chief Commercial Officer | 30.09.2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Hackman Jeffrey S. | Chief Executive Officer | 30.09.2026 | Zuteilung | — | 1.159 | — | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 30.09.2026 | Zuteilung | — | 1.703 | — | Form 4 |
| FENC | Brughera Marco Maria | Director | 15.09.2026 | Verkauf | 10,29 | 15.545 | 159.958 | Form 4 |
| FENC | Brughera Marco Maria | Director | 15.09.2026 | Optionsausübung | 2,11 | 15.545 | 32.800 | Form 4 |
| FEAM | Malm Joshua | Chief Financial Officer | 15.09.2026 | Steuer-Abgabe | 1,26 | 1.225 | 1.544 | Form 4 |
| FEAM | Malm Joshua | Chief Financial Officer | 15.09.2026 | Optionsausübung | — | 4.261 | — | Form 4 |
| FEAM | Weibel Paul Wesley III | Chief Executive Officer | 15.09.2026 | Steuer-Abgabe | 1,26 | 1.839 | 2.317 | Form 4 |
| FEAM | Weibel Paul Wesley III | Chief Executive Officer | 15.09.2026 | Zuteilung | — | 795 | — | Form 4 |
| FEAM | Weibel Paul Wesley III | Chief Executive Officer | 15.09.2026 | Optionsausübung | — | 4.322 | — | Form 4 |
| FEIM | Mcclelland Thomas | President and CEO | 09.09.2026 | Zuteilung | — | 50.000 | — | Form 4 |
| FELE | Sengstack Gregg C | Director | 01.09.2026 | Steuer-Abgabe | 98,43 | 145 | 14.272 | Form 4 |
| FELE | Sengstack Gregg C | Director | 01.09.2026 | Zuteilung | 98,43 | 366 | 36.025 | Form 4 |
| FENC | Raykov Rosty | Former Director | 01.09.2026 | Verkauf | 12,11 | 10.000 | 121.100 | Form 4 |
| FENC | Raykov Rosty | Former Director | 31.08.2026 | Zuteilung | — | 2.778 | — | Form 4 |
| FENC | Cioffi Christiana Marie | Chief Strategy Officer | 31.08.2026 | Zuteilung | — | 156 | — | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 31.08.2026 | Verkauf | 12,18 | 12.000 | 146.160 | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 31.08.2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Evans Terry L | Chief Commercial Officer | 31.08.2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Hackman Jeffrey S. | Chief Executive Officer | 31.08.2026 | Zuteilung | — | 1.159 | — | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 31.08.2026 | Zuteilung | — | 1.703 | — | Form 4 |
| FERG | Schlicher Jake | Chief Strategy Officer | 28.08.2026 | Verkauf | 230,92 | 5.177 | 1.195.473 | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 28.08.2026 | Optionsausübung | 5,10 | 21.928 | 111.833 | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 27.08.2026 | Verkauf | 11,78 | 75.000 | 883.500 | Form 4 |
| FET | Williams David Lyle Jr. | EVP, CFO | 20.08.2026 | Verkauf | 81,08 | 100 | 8.108 | Form 4 |
| FET | Williams David Lyle Jr. | EVP, CFO | 20.08.2026 | Verkauf | 80,07 | 300 | 24.021 | Form 4 |
| FET | Williams David Lyle Jr. | EVP, CFO | 20.08.2026 | Verkauf | 78,09 | 19.668 | 1.535.874 | Form 4 |
| FET | Danford Michael Dewayne | SVP & CHO | 14.08.2026 | Verkauf | 85,82 | 1.200 | 102.984 | Form 4 |
| FET | Ivascu John C | EVP, General Counsel & CCO | 11.08.2026 | Verkauf | 82,19 | 991 | 81.450 | Form 4 |
| FET | Ivascu John C | EVP, General Counsel & CCO | 11.08.2026 | Verkauf | 81,38 | 1.909 | 155.354 | Form 4 |
| FET | Ivascu John C | EVP, General Counsel & CCO | 11.08.2026 | Verkauf | 80,62 | 2.100 | 169.302 | Form 4 |
| FET | Danford Michael Dewayne | SVP & CHO | 10.08.2026 | Verkauf | 78,91 | 1.500 | 118.365 | Form 4 |
| FEMY | Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | 07.08.2026 | Kauf | 3,20 | 3.125 | 10.000 | Form 4 |
| FEMY | Sipos Jeremy Alexander | Chief Technology Officer | 07.08.2026 | Kauf | 3,20 | 3.125 | 10.000 | Form 4 |
| FEMY | Canning John Charles | Chief Operating Officer | 07.08.2026 | Kauf | 3,20 | 4.375 | 14.000 | Form 4 |
| FEMY | Elefant Dov | Chief Financial Officer | 07.08.2026 | Kauf | 3,20 | 15.625 | 50.000 | Form 4 |
| FEMY | Lee-Sepsick Kathy | Chief Executive Officer | 07.08.2026 | Kauf | 3,20 | 15.625 | 50.000 | Form 4 |
| FELE | Sengstack Gregg C | Director | 07.08.2026 | Steuer-Abgabe | 109,46 | 11.372 | 1.244.779 | Form 4 |
| FELE | Sengstack Gregg C | Director | 07.08.2026 | Optionsausübung | 43,00 | 18.000 | 774.000 | Form 4 |
| FET | Ivascu John C | EVP, General Counsel & CCO | 03.08.2026 | Verkauf | 71,21 | 1.402 | 99.836 | Form 4 |
| FET | Ivascu John C | EVP, General Counsel & CCO | 03.08.2026 | Verkauf | 70,41 | 3.598 | 253.335 | Form 4 |
| FENC | Raykov Rosty | Former Director | 03.08.2026 | Verkauf | 9,58 | 10.000 | 95.800 | Form 4 |
| FELE | Sengstack Gregg C | Director | 01.08.2026 | Steuer-Abgabe | 104,72 | 145 | 15.184 | Form 4 |
| FELE | Sengstack Gregg C | Director | 01.08.2026 | Zuteilung | 104,72 | 366 | 38.328 | Form 4 |
| FEIM | Mcclelland Thomas | President and CEO | 31.07.2026 | Steuer-Abgabe | 57,97 | 12.888 | 747.117 | Form 4 |
| FEIM | Bernstein Steven Lawrence | CFO | 31.07.2026 | Steuer-Abgabe | 57,97 | 9.022 | 523.005 | Form 4 |
| FENC | Cioffi Christiana Marie | Chief Strategy Officer | 31.07.2026 | Zuteilung | — | 156 | — | Form 4 |
| FENC | Sayad Pierre Sargis | Chief Medical Officer | 31.07.2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Evans Terry L | Chief Commercial Officer | 31.07.2026 | Zuteilung | — | 168 | — | Form 4 |
| FENC | Hackman Jeffrey S. | Chief Executive Officer | 31.07.2026 | Zuteilung | — | 1.159 | — | Form 4 |
| FENC | Raykov Rosty | Former Director | 31.07.2026 | Zuteilung | — | 2.778 | — | Form 4 |
| FENC | Andrade Robert | CHIEF FINANCIAL OFFICER | 31.07.2026 | Zuteilung | — | 1.703 | — | Form 4 |
| FEIM | Edenbrook Capital, LLC | Director | 28.07.2026 | Verkauf | 57,50 | 554.348 | 31.875.010 | Form 4 |
| FEIM | Edenbrook Capital, LLC | Director | 28.07.2026 | Verkauf | 57,50 | 97.826 | 5.624.995 | Form 4 |
| FERG | Baker Kelly A | Director | 09.07.2026 | Zuteilung | 224,20 | 4 | 897 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).